Possible anticancer action mechanism of 17-DMAG against gastric cancer... | Download Scientific Diagram
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
17-AAG protects against A  -induced damage to dendritic spine... | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies | HTML
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells | Journal of Biomedical Science | Full Text
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C | Leukemia
Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner* - Journal of Biological Chemistry
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C | Leukemia
Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway
17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma - ScienceDirect
Tanespimycin - an overview | ScienceDirect Topics
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C | Leukemia
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration | Nature Medicine
17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells
Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes - Organic & Biomolecular Chemistry (RSC Publishing) DOI:10.1039/C5OB00147A
Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment - Talaei - 2019 - Chemical Biology & Drug Design - Wiley Online Library
Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo* - Journal of Biological Chemistry
The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferati | DDDT
Antimyeloma activity of heat shock protein-90 inhibition - ScienceDirect
Vorinostat in solid and hematologic malignancies | Journal of Hematology & Oncology | Full Text
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Structure of 17-AAG. | Download Scientific Diagram
Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells | Journal of Biomedical Science | Full Text
